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Abstract
Background: Despite depression being one of the most prevalent mental disorders in the world, access to
treatment is still insufficient, especially in low- and middle-income countries. The aim of this study is to investigate
differences in access to treatment for depression according to socio-demographic characteristics, geographical area
and multi-morbidity in a nationally representative sample of individuals with depression.
Methods: This study analyses data from the National Health Survey (Pesquisa Nacional de Saúde – PNS), a Brazilian
household-based nationwide survey, which comprises 60,202 adults (aged 18 years or older). Depression was
evaluated through the Patient Health Questionnaire-9 (PHQ-9). Prevalence Ratios and corresponding 95 %
confidence intervals (95%CI) were calculated using Poisson regression.
Results: The general prevalence of depression was 7.9 % (95 % CI 7.5 to 8.3). Among those with depression, 78.8 %
did not receive any treatment, and 14.1 % received only pharmacotherapy. Multivariable analyses showed that
being female, white, aged between 30 and 69 years, living in regions other than the North, having higher
education and having multi-morbidities were independently associated with higher likelihood of access to any
treatment.
Conclusions: Most Brazilians with clinically relevant depressive symptoms are not receiving any treatment. Access
to care is unequal, with the poor and those living in low resource areas having higher difficulties to access mental
health care. Understanding these disparities is important for the provision of effective interventions aimed at
reducing the prevalence of depression and inequities in access to mental health care.
Keywords: Depression, Health surveys, PHQ-9, Mental health, Mental health service access
Background
Depression is one of the most important mental disorders,
both due to its high prevalence worldwide and also
because of the commonly chronic course of its presenta-
tion (leading to a high lifetime prevalence), with a signifi-
cant burden for individuals’ lives and public health
systems [1, 2]. Data from the Global Burden of Disease
Study – 2010 showed that depression is the leading
contributor, accounting for 2.5 % of Disability Adjusted
Life Years (DALYs), and the second leading cause of
disability, accounting for 8.2 % of Years Lived with
Disability (YLDs). Depression was also considered the
main cause of 16 million suicide DALYs and almost 4
million ischaemic heart disease DALYs [3].
Effective treatment for depression includes antidepres-
sant medications and psychotherapies, either alone or in
combination [4]. However, a large proportion of those
with depression do not receive any type of care. It is esti-
mated that 35 to 50 % of individuals with severe depres-
sive symptoms in high-income countries do not receive
any treatment [5, 6]. Moreover, among those receiving
care for depression, only about 20 % get effective treat-
ment. In low- and middle-income countries the situation
is even worse, with only 15 to 25 % of those with severe
depressive symptoms receiving any treatment [5]. Lack
of specialized human resources and adequate budgets
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for mental health care account for a great deal of this
huge deficiency [6]. This treatment gap is marked by
social and geographical disparities, those who most need
care, such as the poor and those living in where regions
with limited mental health resources having greater diffi-
culty receiving adequate care for depression.
In Brazil, a 2013 population-based survey with a na-
tionally representative sample, the National Health
Survey (PNS), showed that the prevalence of major
depression is higher among women, those living in
urban areas, those with lower educational levels, and
those with chronic conditions, such as hypertension and
diabetes [7]. The data also showed that the lowest preva-
lence was observed in the Northern region, whereas the
highest prevalence was found in the Southern region.
In present study, we used the PNS data to examine the
extent of the treatment gap for depression in Brazil and
associated inequities. We aimed to: 1) estimate the pro-
portion of Brazilians with clinically relevant depressive
symptoms who have access to treatment; and 2) evaluate
differences in access to treatment according to sociode-
mographic characteristics, geographical area and pres-
ence of multi-morbidity among those presenting
clinically relevant depressive symptoms.
Methods
Study design and sample
This study analyzed data from the National Health
Survey (PNS), a household-based nationwide survey
conducted by the Ministry of Health, in partnership with
the Brazilian Institute of Geography and Statistics
(IBGE), in 2013. The scope of the survey was to establish
the health status and lifestyles of the population - as well
as to examine aspects of access to and use of preventive
and therapeutic services, continuity of care and health
care financing.
The survey sample was designed to allow for the esti-
mation of indicators for Brazil and at different geo-
graphic levels, namely major regions, states, capitals, and
metropolitan and rural areas. The sampling design was
by clusters in three stages: In the first stage, census
tracts or set of sectors were selected to from the primary
sampling units (PSUs). In the second stage, households
were randomly selected within each PSU. In the third
stage, an adult resident (18 years old or older) was
selected with equal probability among all adult residents
in the household. Weighting factors were calculated for
each of the three sampling units, considering the prob-
abilities of selection and the non-response rate. For the
selected resident, the weighting factor was calculated
considering the weight for the corresponding household,
the probability of selection of the resident, the adjust-
ment of non-response for sex, and calibration for the
total population by sex and age groups estimated with
the weight of all residents. More information about
the design and methodology of the study, including
the sampling process, can be obtained in previous
publications [8, 9].
After forecasting a rate of 23 % non-response, the esti-
mated sample size needed was 81,357 households.
Losses were considered when households were closed or
uninhabited; residents refused to answer the interview;
or residents were not found after three or more
attempts, even with scheduling visits. In the final survey,
a total of 69,954 occupied households were visited and
60,202 individuals were interviewed, resulting in a
response rate of 86.1 %.
The PNS project was approved by the National
Commission of Ethics in Research (CONEP) in June
2013, Regulation No. 328.159, and all participants
signed an informed consent agreement.
Measures
Data were collected by research assistants, supervisors
and coordinators of the IBGE, through a structured
questionnaire using a Personal Digital Assistant (PDA).
The questionnaire addressed a variety of health issues,
lifestyle, socio-demographic and economic characteris-
tics, among others. For the present study, we analyzed
data focused on depressive symptoms, physical morbid-
ity, use of health services and socio-demographic charac-
teristics (gender, age, marital status, educational level
and skin color).
Measurement of depression
For the evaluation of depression, we used the Brazilian
version of the Patient Health Questionnaire (PHQ-9)
[10], which is the depression module of the Primary
Care Evaluation of Mental Disorders (PRIME-MD) [11].
Each item of the PHQ-9 covers one symptom of depres-
sion according to criteria for the diagnosis of depression
established by the Diagnostic and Statistical Manual of
Mental Disorders, Fourth Edition (DSM-IV). For each
item, possible answers and respective scores are: (0) ‘not
at all’, (1) ‘less than half of the days’, (2) ‘more than half
of the days’, and (3) ‘almost every day’. Total PHQ-9
scores of 5–9, 10–14, 15–19 and 20 or more represent
mild, moderate, moderately severe, and severe depres-
sion, respectively [12].
A population-based validation study, conducted in a
medium-sized Brazilian city, demonstrated that the
PHQ-9 exhibited good validity in diagnosing major
depression at the cut-offs of ≥ 9 and ≥ 10. The same
study found that the PHQ-9 had a sensitivity of 72.5 %
(95 % confidence interval (CI): 61.5 to 89.2) and a speci-
ficity of 88.9 % (95 % CI: 83.0 to 89.9) in identify major
depression using the cut-off point ≥ 10 [10].
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In the present study, depression was defined by a
PHQ-9 score of 10 or higher, which is considered as the
presence of clinically relevant depressive symptoms that
can benefit from treatment (pharmacotherapy and/or
psychotherapy) [12].
Access to treatment for depression
For the assessment of access to treatment by those pre-
senting depression, we used a question that asked
whether the individual was currently seeing a doctor or
health service regularly for depression. For those who
answered “yes”, another question was used to classify
the type of treatment received (psychotherapy, medica-
tion, or both). For those who answered that they were
receiving medication, further questions assessed if these
were acquired at a public health service, through some
type of health plan or insurance, or whether it was paid
for by the individual out of pocket.
Predictors of treatment
Socio-demographic characteristics investigated were: gen-
der (male and female); age group (18–29; 30–39; 40–49;
50–59; 60–69; 70 years or over); race/skin color; level of
education (uneducated or incomplete primary school;
complete primary school or incomplete high school,
complete high school or incomplete college/university,
complete college/university); and marital status (married
or living with a partner vs. single). Geographical areas
were defined as macro-region of residence (North,
Northeast, Center-west, Southeast, and South), and
living in urban vs. rural areas. Multi-morbidity was
evaluated through self-reported physician diagnosis of
the following conditions: arterial hypertension, dia-
betes, cardiac diseases, stroke, asthma, arthritis/
rheumatism, back pain, chronic obstructive pulmonary
disease, renal failure, cancer, musculoskeletal disorder
related to working, other mental illnesses and other
chronic diseases. Individuals were classified as having
none, one, two or three or more of these conditions.
Statistical analysis
Initially, a descriptive analysis was carried out and the
resulting frequencies were adjusted according to the
sample design and expanded for the Brazilian popula-
tion. Prevalence of depression was described according
to socio-demographic characteristics, geographical area
and multi-morbidity. Among those with depression, the
type of treatment received and the acquisition of medi-
cines were presented stratified by geographic region of
residence. For the evaluation of predictors of treatment,
a multivariate analysis was carried out using Poisson
regression, and prevalence ratios of access to treatment
with their 95 % confidence intervals for the association
between socio-demographic characteristics, geographical
area of residence and multi-morbidity and access to
treatment for depression were estimated. Crude and
adjusted analyses were performed. Variables that pre-
sented a p-value of 0.20 in each level were maintained in
the adjusted analysis. Analyses were performed using the
Stata 14.0 statistical package. The survey svyset com-
mand was used to account for the effects of the complex
design and included final sampling weights (Stata Corp.
College Station, United States).
Results
Table 1 shows the characteristics of the study population,
the weighted projection for the Brazilian adult population
and the prevalence of depression according to individual
characteristics. The sample was composed of 60,202 indi-
viduals, of whom 52.9 % were female, 47.5 % declared that
their skin color was white, more than 86 % lived in urban
areas, 47.1 % were between 18 and 39 years old, 43.8 %
lived in the Southeast region, 61.2 % lived with a partner,
38.3 % were uneducated or had incomplete primary edu-
cation, and 47.9 % of subjects had no morbidity. The
prevalence of depression was 7.9 % (95 % CI 7.5 to 8.2),
corresponding to 11,553,035 (95 % CI 10,970,345 to
12,135,726) individuals.
Figure 1 shows the type of treatment received among
individuals with depression. The proportion of individ-
uals not receiving any treatment was almost 80 % in
Brazil. The Northern region had the highest proportion
of untreated individuals (over 90 %), and the Southern
region, the lowest proportion (67.5 %). The most com-
mon type of treatment was pharmacotherapy only, in all
regions (around 14 % in Brazil); the Southern region had
the highest proportion of individuals who received
pharmacotherapy alone (21.6 %) or in addition to psy-
chotherapy (9.3 %). Regarding the acquisition of medi-
cines among individuals who had depression and
received pharmacotherapy, 47.4 % acquired it through
the public system, 41.8 % had to buy it, and just over
10 % acquired their medicines through a private health
plan/insurance (Fig. 2). The highest proportions of users
acquiring medications through the public system were
observed in the Southern and Northeastern regions.
Table 2 includes crude and adjusted prevalence ratios
of associations between socio-demographic characteris-
tics, geographical areas and multi-morbidity and access
to treatment among participants with depression. In the
bivariate analysis, only marital status was not signifi-
cantly associated with receiving any type of depression
treatment. Multivariable Poisson regression showed that
being female, white, between 30 to 69 years old, living in
a macro-region other than the North, having a college/
university degree and having multi-morbidities were all
independently associated with higher likelihood of hav-
ing access to treatment for depression.
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Discussion
This is the first study to present nationally representative
estimates of access to treatment for depression, and
predictors of access among Brazilians with depression.
Approximately 80 % of individuals with clinically relevant
depressive symptoms have not received any treatment,
Table 1 Sociodemographic characteristics, multimorbidity and prevalence of depression (PHQ-9 ≥ 10) for the Brazilian adult
population. PNS/Brazil, 2013. (n = 60,202; weighted n = 146,308,458)
Variables Depression
n Weighted na % Weighted na %
Gender
Male 25,920 68,916,470 47.1 3,255,511 4.7
Female 34,282 77,391,988 52.9 8,297,524 10.7
Age
18 to 29 14,321 38,157,850 26.1 2,174,491 5.7
30 to 39 14,269 31,643,091 21.6 2,314,648 7.3
40 to 49 11,405 26,423,124 18.0 2,305,212 8.7
50 to 59 9,030 23,676,562 16.2 2,294,739 9.7
60 to 69 6,238 14,894,253 10.2 1,277,645 8.6
70 or more 4,939 11,513,578 7.9 1,186,299 10.3
Education
None or incomplete primary school 24,083 57,041,784 39.0 5,841,390 10.2
Complete primary school or incomplete high school 9,215 22,761,619 15.5 1,776,611 7.8
Complete high school or incomplete college/university 19,149 48,109,933 32.9 2,871,793 6.0
Complete college/university 7,603 18,395,122 12.6 1,075,825 5.8
Race/skin color
Black 5,631 13,454,163 9.2 1,150,680 8.6
White 24,106 69,441,261 47.5 5,198,101 7.5
Asian 533 1,371,822 0.9 105,306 7.7
Brown 29,512 61,418,883 42.0 5,048,783 8.2
Indigenous 417 619,019 0.4 50,165 8.1
Marital status
Married or living with a partner 34,522 89,537,328 61.2 6,899,008 7.7
Single or no partner 25,680 56,771,130 38.8 4,654,027 8.2
Macro-region
North 12,536 10,885,968 7.4 659,268 6.1
Northeast 18,305 38,947,575 26.6 3,121,942 8.0
Center-west 7,519 10,775,569 7.4 885,227 8.2
Southeast 14,294 64,074,682 43.8 4,913,627 7.7
South 7,548 21,624,664 14.8 1,972,971 9.1
Geographical area
Urban 49,245 126,132,422 86.2 10,260,840 8.1
Rural 10,957 20,176,036 13.8 1,292,195 6.4
Multimorbidity
None 33,768 80,093,878 54.8 3,003,770 3.8
One 15,378 37,632,350 25.7 3,210,081 8.5
Two 6,749 17,328,645 11.8 2,384,125 13.8
Three or more 4,307 11,253,585 7.7 2,955,058 26.3
aEstimated values for Brazilian adult population
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with the Northern region having the highest proportion of
untreated individuals and the Southern region having the
lowest proportion. For those receiving treatment, pharma-
cotherapy only was most common, especially among indi-
viduals from the Southern region. With respect to
acquisition of medicines, most people with depression had
access to free drugs in the public health system (47.4 %),
and this proportion was markedly higher in the South
(54.6 %) and lower in the North (34.8 %). However, a con-
siderable portion of individuals had to pay for their medi-
cines (41.8 %). It is noteworthy that in three regions
(North, Midwest and Southeast), the proportion of indi-
viduals who had to buy medicines for depression was
higher than that of those who obtained their medications
for free.
Our findings are in accordance with previous studies.
Wittayanukorn et al. [2], using NHANES data, estimated
the prevalence of depressive symptoms and type of treat-
ment across PHQ-9 symptom severity in the U.S. popu-
lation. They found that approximately 70 % of
individuals with any depressive symptoms and over half
of those with moderate to severe depression did not
receive any treatment. Other studies have also called
attention to the low and inadequate access to depression
treatment [13–17]. Kessler et al. [16], in a household
survey of psychiatric disorders among adult residents in
the U.S. found that more than half (57 %) of respondents
with 12-month major depressive disorder (MDD)
received any treatment in the 12 months before the
interview, and the treatment received was considered
adequate for only 20.9 % of these individuals. In a sys-
tematic assessment of patients with major depression
presenting for treatment, Kocsis et al. [17] showed that
only 33 % of the 801 registered participants had ever
had a prior adequate course of antidepressant medica-
tion. Young et al. [13], using data from a cross-sectional
telephone survey that included 1636 adults with prob-
able depressive or anxiety disorder in the USA, found
that 83 % of them saw a health care provider, but only
30 % received appropriate treatment.
In the present study, women, white individuals, those
with college/university degrees, and those presenting
Fig. 1 Receipt of treatment between depressed individuals. Brazil and regions. PNS/Brazil, 2013. (n = 5.501)
Fig. 2 Type of acquisition between depressed individuals who were receiving medication. Brazil and regions. PNS/Brazil, 2013. (n = 619)
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with multi-morbidities were more likely to have access
to treatment for depression. These findings reveal import-
ant inequities in access to treatment among individuals
with depression in Brazil and are broadly consistent with
those of other studies [2, 17]. The study conducted by
Wittayanukorn et al. [2] found similar treatment dispar-
ities in the U.S. population, showing that among patients
with moderate to severe depression, being female, white,
Table 2 Crude and adjusted analyses of the associations between sociodemographic characteristics and multimorbidity with access
to treatment among individuals with depression. PNS/Brazil, 2013. (n = 5.051)
Variables No treatment (%) Crude PRa (95 % CI) Adjusted PRb (95 % CI)
Gender
Male 15.2 1.00 1.00
Female 23.5 1.63 (1.37-1.93) 1.42 (1.14-1.77)
Race/skin color
Black 16.3 1.00 1.00
White 25.3 1.69 (1.29-2.23) 1.66 (1.22-2.26)
Asian 23.2 0.94 (0.43-2.09) 1.48 (0.72-3.02)
Brown 18.0 1.26 (0.96-1.65) 1.30 (0.94-1.79)
Indigenous 25.7 1.94 (0.79-4.75) 2.49 (1.60-3.86)
Geographical area
Urban 21.7 1.54 (1.26-1.88) 1.03 (0.85-1.25)
Rural 17.3 1.00 1.00
Age
18 to 29 12.8 1.00 1.00
30 to 39 20.7 1.93 (1.50-2.50) 1.69 (1.30-2.20)
40 to 49 25.0 2.73 (2.12-3.51) 1.96 (1.51-2.56)
50 to 59 24.1 3.13 (2.44-4.02) 1.94 (1.48-2.55)
60 to 69 30.1 2.85 (2.17-3.75) 1.63 (1.20-2.20)
70 or more 14.7 1.80 (1.31-2.48) 1.00 (0.71-1.43)
Macro-region
North 9.8 1.00 1.00
Northeast 13.7 1.44 (1.14-1.82) 1.31 (1.04-1.67)
Center-west 14.1 1.63 (1.24-2.14) 1.34 (1.01-1.76)
Southeast 24.1 2.14 (1.70-2.69) 1.75 (1.38-2.22)
South 32.5 2.97 (2.34-3.76) 2.16 (1.68-2.79)
Marital status
Married or living with a partner 22.3 1.00 1.00
Single or no partner 19.4 1.08 (0.95-1.22) 1.11 (0.97-1.27)
Education
None or incomplete primary school 22.2 1.00 1.00
Complete primary school or incomplete high school 18.1 0.90 (0.74-1.09) 1.02 (0.83-1.25)
Complete high school or incomplete college/university 18.0 0.90 (0.77-1.05) 1.09 (0.92-1.30)
Complete college/university 29.7 1.46 (1.20-1.78) 1.37 (1.11-1.70)
Multimorbidity
None 11.0 1.00 1.00
One 18.9 1.69 (1.35-2.10) 1.52 (1.22-1.90)
Two 23.8 2.68 (2.16-3.32) 2.28 (1.82-2.86)
Three or more 31.9 3.45 (2.82-4.22) 2.83 (2.27-3.53)
aPR Prevalence Ratio
b Adjusted for all variables shown in Table 2
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and having comorbidities, increased the likelihood of
receiving treatment. Kocsis et al. [17] also showed
that patients who were white or had comorbidities
were significantly more likely to have received prior
adequate antidepressant treatment. Young et al. [13]
found that appropriate treatment was less likely for
men and those who were black and less educated
compared to their female, white and more educated
counterparts. A population-based, long-term prospect-
ive cohort study conducted by Hengartner et al. [18]
including 4,547 adults from Zurich showed that the
weighted treatment prevalence for any depressive
disorder was 23.4 % (15.7 % for MDE, 4.3 % for
minor depressive disorders and 3.4 % for non-
diagnosed subjects), and that women with MDE had a
treatment prevalence three times larger than that of
men (23.8 vs 7.4 %).
In the present study, despite the higher prevalence of
depression among non-white skinned individuals, we
found that being white increased the likelihood of
receiving any treatment for depression. Evidence of an
association between skin color and access to depression
treatment has also been reported in other studies that
evaluated specifically racial/ethnic disparities. For in-
stance, Simpson et al. [19], in a systematic review of the
literature to evaluate racial disparities in the diagnosis
and treatment of depression in the U.S., found lower
rates of treatment for African Americans and Hispanics
when compared to Caucasians. Also, Alegría et al. [20],
using nationally representative data in a study conducted
in the U.S. population, found that among those reporting
a depressive disorder in the past year, Latinos, Asians,
and African Americans had less access to any mental
health treatment when compared to non-Latino whites.
Education has been considered an important factor as-
sociated with better access to adequate treatment for de-
pression. Witt et al. [21] using data from the 1996–2005
Medical Expenditure Panel Survey to evaluate access to
adequate treatment among mothers with depression,
found that those with less education were less likely to
receive treatment. The HealthCare for Communities
(HCC) study also showed that among individuals with a
depressive or anxiety disorder, receipt of appropriate
care was significantly more likely among individuals with
more years of education [13].
Living in the Northern region was associated with
lower likelihood of receiving treatment for depression,
independently of individual characteristics. This prob-
ably reflects Brazilian regional inequities in the distribu-
tion of health services and specialized health care
professionals. In fact, a recent survey indicated that in
the Southeast region, where 43.8 % of the Brazilian
population lives, there were 4,104 psychiatrists, corre-
sponding to one psychiatrist for every 15,000 people. In
contrast, the North region, where 7.4 % of the popula-
tion lives, had only 134 psychiatrists, corresponding to
one psychiatrist for more than 80,000 people [22].
Limitations
Our study has some limitations. Presence of depression
was assessed with the PHQ-9, and pooled estimates of
sensitivity and specificity for the cut-off 10 are 0.77 and
0.85, respectively, implying that some degree of random
misclassification occurred. This may have diluted
observed associations. Access to treatment was based on
self-report, and individuals with higher socioeconomic
conditions may have better awareness of medical diagno-
ses and treatments they receive. We were not able to
control for some relevant characteristics, such as in-
come, therefore some of the observed associations may
be affected by uncontrolled confounding.
Implications
Several strategies must be implemented in order to over-
come barriers, improve access to treatment for depres-
sion, and reduce health care inequities in Brazil. Such
strategies involve actions to overcome attitudinal bar-
riers, which are related to personal beliefs and social
stigma, and structural barriers, related to the way health
care is delivered and accessible to the population [23]. In
Brazil, as in many low- and middle-income countries,
there is an urgent need for dissemination of information
about depression and its treatments, in order to increase
awareness and reduce social stigma, which is still very
high [24]. Regarding structural barriers, integrating men-
tal health into primary care is essential, and must involve
several strategies. In Brazil, primary care covers most of
the population [25]. However, primary care staff are still
largely ill-prepared to deal with mental health problems.
Screening for depressive symptoms is important but not
effective by itself. Task-shifting strategies that allow less
specialized primary care staff to deliver effective treat-
ment need to be developed and tested. Public policies
must target vulnerable groups, such as non-white indi-
viduals, in order to reduce inequities related to ethni-
city/skin color. Special attention must be paid to men’s
health programs, since men are less likely to seek help
and health care staff are not well prepared to identify
they health care needs, including the need for mental
health care [26].
Conclusion
In Brazil, access to treatment is very low, and those most
vulnerable are less likely to receive care for depression.
Tackling this important health inequity requires a series
of actions and public policies aimed at overcoming bar-
riers to access to mental health care.
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